NM_000404.4:c.1321G>A
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM2PP2PP3_StrongPP5_Very_Strong
The NM_000404.4(GLB1):c.1321G>A(p.Asp441Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,613,906 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D441G) has been classified as Uncertain significance.
Frequency
Consequence
NM_000404.4 missense
Scores
Clinical Significance
Conservation
Publications
- GM1 gangliosidosisInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, ClinGen
- GM1 gangliosidosis type 3Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
- mucopolysaccharidosis type 4BInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- GM1 gangliosidosis type 1Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
- GM1 gangliosidosis type 2Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000404.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GLB1 | NM_000404.4 | MANE Select | c.1321G>A | p.Asp441Asn | missense | Exon 13 of 16 | NP_000395.3 | ||
| GLB1 | NM_001317040.2 | c.1465G>A | p.Asp489Asn | missense | Exon 14 of 17 | NP_001303969.2 | |||
| GLB1 | NM_001079811.3 | c.1231G>A | p.Asp411Asn | missense | Exon 13 of 16 | NP_001073279.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GLB1 | ENST00000307363.10 | TSL:1 MANE Select | c.1321G>A | p.Asp441Asn | missense | Exon 13 of 16 | ENSP00000306920.4 | ||
| GLB1 | ENST00000307377.12 | TSL:1 | c.928G>A | p.Asp310Asn | missense | Exon 10 of 13 | ENSP00000305920.8 | ||
| GLB1 | ENST00000399402.7 | TSL:2 | c.1231G>A | p.Asp411Asn | missense | Exon 13 of 16 | ENSP00000382333.2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152024Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000120 AC: 3AN: 249578 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461882Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 727244 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152024Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74250 show subpopulations
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Published functional studies of this variant found that it is associated with no detectable enzyme activity compared to wild-type (PMID: 17664528); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 16941474, 26223439, 38702915, 17664528, 21497194)
GM1 gangliosidosis;C0086652:Mucopolysaccharidosis, MPS-IV-B Pathogenic:1
This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 441 of the GLB1 protein (p.Asp441Asn). This variant is present in population databases (rs780724173, gnomAD 0.006%). This missense change has been observed in individual(s) with GLB1-related conditions (PMID: 16941474, 17664528, 21497194). ClinVar contains an entry for this variant (Variation ID: 551496). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt GLB1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects GLB1 function (PMID: 17664528). For these reasons, this variant has been classified as Pathogenic.
Mucopolysaccharidosis, MPS-IV-B;C0268271:Infantile GM1 gangliosidosis;C0268272:GM1 gangliosidosis type 2;C0268273:GM1 gangliosidosis type 3 Pathogenic:1
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at